Filing Details

Accession Number:
0001209191-21-059842
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-10-06 16:38:55
Reporting Period:
2021-10-04
Accepted Time:
2021-10-06 16:38:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1566373 F-Star Therapeutics Inc. FSTX Pharmaceutical Preparations (2834) 522386345
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1831519 Louis Kayitalire C/O F-Star Therapeutics, Inc.
Eddeva B920, Babraham Research Campus
Cambridge X0 CB22 3AT
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-10-04 64 $7.23 54,319 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Shares sold pursuant to the 10b5-1 Plan entered into by the Reporting Person.
  2. Includes 47,175 restricted stock units.